Researchers are optimistic the effectiveness of Enhertu will expand treatment options for breast cancer A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the
Researchers are optimistic the effectiveness of Enhertu will expand treatment options for breast cancer A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the